<- Go Home

Bausch Health Companies Inc.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Market Cap

$1.8B

Volume

2.4M

Cash and Equivalents

$1.3B

EBITDA

$3.6B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$7.5B

Profit Margin

71.04%

52 Week High

$8.69

52 Week Low

$4.57

Dividend

N/A

Price / Book Value

-0.89

Price / Earnings

-1.51

Price / Tangible Book Value

-0.11

Enterprise Value

$22.3B

Enterprise Value / EBITDA

6.00

Operating Income

$2.4B

Return on Equity

185.33%

Return on Assets

5.93

Cash and Short Term Investments

$1.3B

Debt

$20.8B

Equity

-$1.1B

Revenue

$10.5B

Unlevered FCF

$2.1B

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches